Sign Out
Use in Pregnancy: Carboplatin may cause fetal harm when administered to a pregnant woman. Carboplatin has been shown to be embryotoxic and teratogenic in rats. If this drug is used during pregnancy or if the patient becomes pregnant while receiving carboplatin, the patient should be apprised of the potential hazard to the foetus. Women of child bearing potential should be advised to avoid becoming pregnant.
Use in Lactation: It is not known whether carboplatin is excreted in human milk. Because there is a possibility of toxicity in nursing infants secondary to carboplatin treatment of the mother, it is recommended that breast feeding be discontinued if the mother is being treated with Carboplatin.
